European equities traded in the US as American depositary receipts were slightly higher late Friday morning, up 0.11% to 1,475.45 on the S&P Europe Select ADR Index, which ended the week more than 1% lower.
From continental Europe, the gainers were led by biopharmaceutical companies Genfit (GNFT) and DBV Technologies (DBVT), which advanced 2.6% and 5% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and oil and gas company TotalEnergies (TTE), which were up 0.1% and 0.6% respectively.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and internet browser company Opera (OPRA), which fell 7% and 0.9% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and internet advertising firm Criteo (CRTO), which were down 1.6% and 0.5% respectively.
From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO), which increased 2.5% and 3.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and utilities company National Grid (NGG), which rose 1.5% and 0.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA), which lost 4.9%. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and financial services company Barclays (BCS), which were off 0.1% and 0.8% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。